Hantz Financial Services Inc. Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Hantz Financial Services Inc. boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 105.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 31,772 shares of the medical equipment provider’s stock after acquiring an additional 16,322 shares during the period. Hantz Financial Services Inc.’s holdings in Intuitive Surgical were worth $17,994,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Holos Integrated Wealth LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. lifted its position in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $27,000. Olistico Wealth LLC bought a new stake in Intuitive Surgical in the fourth quarter worth $28,000. Finally, Caitlin John LLC bought a new stake in Intuitive Surgical in the third quarter valued at approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $438.10 on Monday. The business’s 50-day moving average is $458.62 and its 200 day moving average is $510.37. Intuitive Surgical, Inc. has a 12 month low of $417.74 and a 12 month high of $603.88. The company has a market capitalization of $155.16 billion, a P/E ratio of 53.10, a P/E/G ratio of 3.50 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the business earned $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 23.0% compared to the same quarter last year. On average, research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on ISRG shares. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price on the stock in a research note on Wednesday, March 11th. The Goldman Sachs Group upped their target price on shares of Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. HSBC cut their price target on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday. Finally, Bank of America lowered their price objective on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $579.33.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive unveiled more than 100 upcoming upgrades for its da Vinci 5 robotic surgery system, including improved force-feedback tools, telecollaboration features, and security/reliability enhancements, which could strengthen the company’s competitive moat and support future procedure growth. Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors
• Positive Sentiment: Intuitive also announced innovations tied to its “Quintuple Aim” strategy, reinforcing product development momentum and the company’s push to improve surgeon autonomy and operating-room efficiency. Intuitive Announces Innovations to Advance Quintuple Aim
• Positive Sentiment: Wall Street commentary remains moderately optimistic, with analysts still bullish on Intuitive Surgical’s long-term prospects despite recent underperformance versus the broader market. Are Wall Street Analysts Bullish on Intuitive Surgical Stock?
• Neutral Sentiment: Investor interest continues around the SP platform, where strong procedure growth suggests an important future opportunity, but it remains unclear whether this is true addressable-market expansion or mostly a shift within existing robotic procedures. ISRG’s SP Platform: Early-Stage Growth or Next TAM Expansion Driver?
• Neutral Sentiment: There was also minor insider selling by an executive, but the transactions were very small and made under a pre-arranged 10b5-1 plan, so the signal for investors is limited. Mark Brosius insider transaction
• Negative Sentiment: The stock has also been hurt by recent weakness after earnings, with market commentary noting a roughly 7% decline since the last report, reflecting concern that the shares may need more proof of sustained acceleration. Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report?
• Negative Sentiment: Several articles also point out that ISRG has significantly lagged the market over the past six months, which may be keeping valuation-sensitive investors on the sidelines. 3 Big Reasons ISRG Should Be On Your Watchlist

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The SEC filing for this sale provides additional information. Insiders have sold a total of 5,701 shares of company stock worth $2,783,807 in the last ninety days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.